Eckert & Ziegler SE
EUZ
Rank in Stocks
#8799
Eckert & Ziegler SE manufactures and sells isotope technology components in... Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration-related sources for radioisotopes. In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
Share Price
$15.52
Last synced: 2026-11-09
Market Cap
$971.25M
Change (1 day)
0.89%
Change (1 year)
-13.01%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Eckert & Ziegler SE (EUZ)
Category
Healthcare
EPS for Eckert & Ziegler SE (EUZ)
EPS as of June 2026 TTM: $0.89
According to Eckert & Ziegler SE's latest financial reports, its current EPS (TTM) is $0.89. At the end of 2025 the company had an EPS of $0.92, an increase over its 2024 EPS of $0.55.
EPS history for Eckert & Ziegler SE from 2002 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.89 | -3.03% |
| 2025 | $0.92 | 65.93% |
| 2024 | $0.55 | 18.81% |
| 2023 | $0.46 | -7.92% |
| 2022 | $0.50 | -20.35% |
| 2021 | $0.63 | 40.46% |
| 2020 | $0.45 | 12.62% |
| 2019 | $0.40 | 33.90% |
| 2018 | $0.30 | 6.71% |
| 2017 | $0.28 | 77.44% |
| 2016 | $0.16 | -14.52% |
| 2015 | $0.18 | 43.10% |
| 2014 | $0.13 | -34.55% |
| 2013 | $0.20 | -8.50% |
| 2012 | $0.22 | -0.14% |
| 2011 | $0.22 | 7.58% |
| 2010 | $0.20 | -52.33% |
| 2009 | $0.42 | 151.56% |
| 2008 | $0.17 | 114.36% |
| 2007 | $0.08 | 0.00% |
| 2006 | 0.00 | -100.00% |
| 2005 | $0.05 | -58.03% |
| 2004 | $0.12 | -390.48% |
| 2003 | $-0.04 | -537.50% |
| 2002 | $0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.45 | 847.20% |
IE
|
|
| $0.21 | -76.63% |
CN
|
|
| $19.69 | 2,107.02% |
CH
|
|
| $4.34 | 386.27% |
CH
|
|
| $0.13 | -85.88% |
CN
|
Questions about Eckert & Ziegler SE's earnings per share (EPS)
What is Eckert & Ziegler SE's earnings per share (EPS)?
Eckert & Ziegler SE's earnings per share (EPS) over the last twelve months is $0.89, as of Jun 2026.
What was Eckert & Ziegler SE's earnings per share (EPS) in 2025?
In 2025, Eckert & Ziegler SE's earnings per share (EPS) was $0.92, 67.27% more than in 2024 ($0.55).
How has Eckert & Ziegler SE's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Eckert & Ziegler SE's earnings per share (EPS) went from $0.45 to $0.92, an average growth of 15.38% a year.
How does Eckert & Ziegler SE's earnings per share (EPS) compare with similar companies?
Eckert & Ziegler SE's earnings per share (EPS) ($0.89) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Ypsomed Holding AG, with $19.69.